These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 19169530)

  • 1. [Adverse effects associated with facial application of botulinum toxin: a systematic review with meta-analysis].
    Zagui RM; Matayoshi S; Moura FC
    Arq Bras Oftalmol; 2008; 71(6):894-901. PubMed ID: 19169530
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Blepharospasm and hemifacial spasm. Randomized trial to determine the most appropriate location for botulinum toxin injections.
    Price J; Farish S; Taylor H; O'Day J
    Ophthalmology; 1997 May; 104(5):865-8. PubMed ID: 9160036
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of botulinum toxin A in the treatment of hemifacial spasm and blepharospasm.
    Chang LB; Tsai CP; Liao KK; Kao KP; Yuan CL; Yen DJ; Lin KP
    Zhonghua Yi Xue Za Zhi (Taipei); 1999 Jan; 62(1):1-5. PubMed ID: 10063705
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Botulinum toxin in the treatment of blepharospasm and hemifacial spasm.
    Kenney C; Jankovic J
    J Neural Transm (Vienna); 2008; 115(4):585-91. PubMed ID: 17558461
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term efficacy and safety of botulinum toxin A injections to treat blepharospasm and hemifacial spasm.
    Ababneh OH; Cetinkaya A; Kulwin DR
    Clin Exp Ophthalmol; 2014 Apr; 42(3):254-61. PubMed ID: 23844601
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Botulinum toxin A: experience in the treatment of 115 patients].
    Andrade LA; Borges V; Ferraz HB; Azevedo-Silva SM
    Arq Neuropsiquiatr; 1997 Sep; 55(3B):553-7. PubMed ID: 9629404
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of hemifacial spasm with botulinum toxin.
    Kobayashi T; Sugasawa K; Ishii K; Takeuchi N
    Eur Arch Otorhinolaryngol; 1994 Dec; ():S193-4. PubMed ID: 10774348
    [No Abstract]   [Full Text] [Related]  

  • 8. Effects of botulinum toxin-B (BTX-B) injections for hemifacial spasm.
    Tousi B; Perumal JS; Ahuja K; Ahmed A; Subramanian T
    Parkinsonism Relat Disord; 2004 Oct; 10(7):455-6. PubMed ID: 15465407
    [No Abstract]   [Full Text] [Related]  

  • 9. [Essential blepharospasm and hemifacial spasm: characteristic of the patient, botulinum toxin A treatment and literature review].
    Schellini SA; Matai O; Igami TZ; Padovani CR; Padovani CP
    Arq Bras Oftalmol; 2006; 69(1):23-6. PubMed ID: 16491229
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Botulinum toxin injections for the treatment of hemifacial spasm over 16 years.
    Sorgun MH; Yilmaz R; Akin YA; Mercan FN; Akbostanci MC
    J Clin Neurosci; 2015 Aug; 22(8):1319-25. PubMed ID: 26100157
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Treatment of facial spasm using botulinum toxin].
    Asanuma K; Kaji R
    No Shinkei Geka; 2003 May; 31(5):487-91. PubMed ID: 12755021
    [No Abstract]   [Full Text] [Related]  

  • 12. Thyroid eye disease presenting after cosmetic botulinum toxin injections.
    Harrison AR; Erickson JP
    Ophthalmic Plast Reconstr Surg; 2006; 22(5):397-8. PubMed ID: 16985431
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term botulinum toxin treatment of benign essential blepharospasm, hemifacial spasm, and Meige syndrome.
    Czyz CN; Burns JA; Petrie TP; Watkins JR; Cahill KV; Foster JA
    Am J Ophthalmol; 2013 Jul; 156(1):173-177.e2. PubMed ID: 23541393
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Re: "thyroid eye disease presenting after cosmetic botulinum toxin injections".
    Baldeschi L; Lupetti A; Wiersinga WM
    Ophthalmic Plast Reconstr Surg; 2007; 23(6):498-9; author reply 499. PubMed ID: 18030134
    [No Abstract]   [Full Text] [Related]  

  • 15. Long-term enhancement of botulinum toxin injections by upper-eyelid surgery in 14 patients with facial dyskinesias.
    Mauriello JA; Keswani R; Franklin M
    Arch Otolaryngol Head Neck Surg; 1999 Jun; 125(6):627-31. PubMed ID: 10367918
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Use of botulinum toxin in ophthalmology: current concepts and problems].
    Tapiero B; Robert PY; Adenis JP; Riss I
    J Fr Ophtalmol; 1997; 20(2):134-45. PubMed ID: 9099272
    [No Abstract]   [Full Text] [Related]  

  • 17. Blepharospasm and hemifacial spasm: a protocol for titration of botulinum toxin dose to the individual patient and for the management of refractory cases.
    Ortisi E; Henderson HW; Bunce C; Xing W; Collin JR
    Eye (Lond); 2006 Aug; 20(8):916-22. PubMed ID: 16531977
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Botulinum-A toxin in the treatment of craniocervical muscle spasms: short- and long-term, local and systemic effects.
    Dutton JJ
    Surv Ophthalmol; 1996; 41(1):51-65. PubMed ID: 8827930
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The management of blepharospasm and hemifacial spasm.
    Elston JS
    J Neurol; 1992 Jan; 239(1):5-8. PubMed ID: 1541971
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Botulinum a toxin treatment of hemifacial spasm and blepharospasm.
    Park YC; Lim JK; Lee DK; Yi SD
    J Korean Med Sci; 1993 Oct; 8(5):334-40. PubMed ID: 8305141
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.